MedTrace Logo

The Effect of Prometheus (R) Liver Support Dialysis on Cerebral Metabolism in Acute Liver Failure

NCT00655304 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 8

Last updated 2011-07-27

No results posted yet for this study

Summary

The main objective of this study is to investigate the effect of Prometheus liver support dialysis on intracranial pressure, cerebral metabolism and circulation in patients with acute liver failure.

Conditions

  • Acute Liver Failure
  • Hepatic Encephalopathy
  • Intracranial Hypertension

Interventions

DEVICE

Prometheus (R) liver support dialysis

6-8 hours of dialysis

DEVICE

CVVHDF (Continuously Veno-Venous Hemodiafiltration)

6-8 hours of dialysis with the CVVHDF system PrismaFlex offered by Gambro (Sweden).

Sponsors & Collaborators

  • Rigshospitalet, Denmark

    lead OTHER

Principal Investigators

  • Peter N Bjerring, MD · Department of Hepatology, Rigshospitalet

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-03-31
Primary Completion
2010-12-31
Completion
2011-06-30

Countries

  • Denmark

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00655304 on ClinicalTrials.gov